-
Electronic (PDF)
-
Site License
-
Enterprisewide
Laboratory Corporation of America Holdings (LH) - Financial and Strategic Analysis Review
GlobalData, July 2010, Pages: 40
Laboratory Corporation of America Holdings (LabCorp) is engaged in providing a wide range of testing services utilized in routine testing, patient diagnosis, and in the monitoring and treatment of various diseases. The company also develops specialty and niche businesses depending on certain types of specialized testing capabilities and client requirements such as oncology testing, HIV genotyping and phenotyping, diagnostic genetics and clinical research trials. The major clients of the company include managed care organizations, physician offices, hospitals, and biotechnology and pharmaceutical companies
Laboratory Corporation of America Holdings Key Recent Developments
Apr 21, 2010 LabCorp Reports Net Earnings Of $136.2 Million In Q1 2010
Mar 26, 2010 LabCorp Offers 21-Marker Genetic Analysis In Association With Double-Blind Process To Customers
Feb 11, 2010 LabCorp Reports Net Earnings Of $555.6 Million In 2009
Feb 11, 2010 LabCorp To Open A New Billing Operations Office In Guilford County
Oct 22, 2009 LabCorp Reports Net Earnings Of $134.6 Million In Q3 2009
This comprehensive SWOT profile of Laboratory Corporation of America Holdings provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including,
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note-: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
-The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key
competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered
in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and
efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
List of Tables
List of Figures
Section 1 - About the Company
Laboratory Corporation of America Holdings - Key Facts
Laboratory Corporation of America Holdings - Key Employees
Laboratory Corporation of America Holdings - Key Employee Biographies
Laboratory Corporation of America Holdings - Major Products and Services
Laboratory Corporation of America Holdings - History
Laboratory Corporation of America Holdings - Company Statement
Laboratory Corporation of America Holdings - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 - Company Analysis
Laboratory Corporation of America Holdings - Business Description
Laboratory Corporation of America Holdings- Corporate Strategy
Laboratory Corporation of America Holdings - SWOT Analysis
SWOT Analysis - Overview
Laboratory Corporation of America Holdings - Strengths
Strength - Efficient Use of Resources
Strength - Expanding Operating Margin
Strength - Quality Focus
Strength - Laboratory Testing Operations and Services
Laboratory Corporation of America Holdings - Weaknesses
Weakness - Limited Investor Confidence
Weakness - Limited Liquidity Position
Weakness - High Selling, General and Administrative Expenses
Weakness - Litigations
Laboratory Corporation of America Holdings - Opportunities
Opportunity - Growing Clinical Laboratory Testing Industry
Opportunity - Introduction of New Tests
Opportunity - Customer Service
Opportunity - Scientific Differentiation
Opportunity - Chronic Kidney Disease Program
Opportunity - Strategic Acquisitions
Laboratory Corporation of America Holdings - Threats
Threat - Rapid Technological Change
Threat - Cost Containment Measures
Threat - Stringent Government Regulations
Threat - Highly Competitive Market
Laboratory Corporation of America Holdings - Key Competitors
Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Company’s Recent Developments
Apr 21, 2010: LabCorp Reports Net Earnings Of $136.2 Million In Q1 2010
Mar 26, 2010: LabCorp Offers 21-Marker Genetic Analysis In Association With Double-Blind Process To Customers
Feb 11, 2010: LabCorp Reports Net Earnings Of $555.6 Million In 2009
Feb 11, 2010: LabCorp To Open A New Billing Operations Office In Guilford County
Oct 22, 2009: LabCorp Reports Net Earnings Of $134.6 Million In Q3 2009
Aug 04, 2009: LabCorp Completes Acquisition Of Monogram Biosciences
Jul 23, 2009: LabCorp Posts Net Earnings Of 136.4 Million In Q2 2009
Jul 17, 2009: Laboratory Corporation Of America, Monogram's Waiting Period Under Antitrust Improvements Expired
Jun 23, 2009: LabCorp Signs Agreement To Acquire Monogram Biosciences
May 06, 2009: LabCorp Elects David P. King As New Chairman
Section 5 - Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer
AmeriPath, Inc.
Bio-Reference Laboratories, Inc.
IMPATH Bankruptcy Liquidating Trust
Quest Diagnostics Incorporated
Transgenomic, Inc.
Clarient, Inc.
Orchid Cellmark Inc.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
